In response to the growing demand for private GP services and medical technology advancements in the UK, the private GP EHR market is expected to expand between 2023 and 2028, according to a report by ResearchAndMarkets. However, concerns about cybersecurity and technical restraints might limit market growth among certain healthcare providers. The increasing integration of EHRs with patient care via AI and wearable technology is set to drive this demand.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
